IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Chinese Clinical Oncology- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

1.76

h-Index

 28

Rank

 7623

SJR

 0.642

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Chinese Clinical Oncology
Abbreviation Chin. Clin. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q2); Oncology (Q3)
h-index 28
Overall Rank/Ranking 7623
SCImago Journal Rank (SJR) 0.642
Impact Score 1.76
Publisher Society for Translational Medicine (STM)
Country Hong Kong
ISSN 23043873, 23043865




About Chinese Clinical Oncology


Chinese Clinical Oncology is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Oncology (Q3). It is published by Society for Translational Medicine (STM). The overall rank of Chinese Clinical Oncology is 7623. According to SCImago Journal Rank (SJR), this journal is ranked 0.642. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 28. The best quartile for this journal is Q2.

The ISSN of Chinese Clinical Oncology journal is 23043873, 23043865. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Chinese Clinical Oncology is cited by a total of 551 articles during the last 3 years (Preceding 2021).


Chinese Clinical Oncology Impact Score 2021-2022


The impact score (IS) 2021 of Chinese Clinical Oncology is 1.76, which is computed in 2022 as per its definition. Chinese Clinical Oncology IS is decreased by a factor of 0.43 and approximate percentage change is -19.63% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Chinese Clinical Oncology Impact Score 2022 Prediction


IS 2021 of Chinese Clinical Oncology is 1.76. If the same downward trend persists, impact score may fall in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Chinese Clinical Oncology. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 1.76
2020 2.19
2019 1.58
2018 1.41
2017 1.68
2016 1.56
2015 0.64
2014 0.33

Chinese Clinical Oncology h-index


  Table Setting

Chinese Clinical Oncology has an h-index of 28. It means 28 articles of this journal have more than 28 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Chinese Clinical Oncology ISSN


The ISSN of Chinese Clinical Oncology is 23043873, 23043865. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Chinese Clinical Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Chinese Clinical Oncology is 7623. According to SCImago Journal Rank (SJR), this journal is ranked 0.642. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Chinese Clinical Oncology Publisher


Table Setting

Chinese Clinical Oncology is published by Society for Translational Medicine (STM). It's publishing house is located in Hong Kong. Coverage history of this journal is as following: 2012-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Chinese Clinical Oncology is Chin. Clin. Oncol.. This abbreviation ('Chin. Clin. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Chinese Clinical Oncology


If your research field is/are related to Medicine (miscellaneous) (Q2); Oncology (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Asia-Pacific Journal of Science and Technology journal 21360 Khon Kaen University,Research and Technology Transfer Affairs Division 6 0.84
Muzeologia a Kulturne Dedicstvo journal 18642 Faculty of Arts Comenius University 6 0.38
Comitatus journal 25906 UCLA Center for Medieval and Renaissance Studies (CMRS) 4 0.00
Journal of Advances in Medical Education and Professionalism journal 27089 Shriaz University of Medical Sciences 1 0.00
Acta Agronomica Sinica(China) journal 16950 Institute of Crop Sciences (ICS) 19 0.93
European Journal of Histochemistry journal 11002 PagePress Publications 44 1.77
Burns and Trauma journal 5968 Oxford University Press 24 4.55
Archives of Cardiovascular Diseases journal 5535 Elsevier Masson s.r.l. 55 2.38
Segle XX journal 25697 Universitat de Barcelona 0 0.00
Chem journal 189 Elsevier Inc. 102 16.16

Check complete list




Year wise Impact Score (IS) of Chinese Clinical Oncology

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 1.76
2020 2.19
2019 1.58
2018 1.41
2017 1.68
2016 1.56
2015 0.64
2014 0.33



Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All